Area of research
Immunology · Oncology
Research interest
Research interests include Medicine, Biology, Virology, Heterologous, Vaccination, and Immunology.
948P Cancer Research UK first-in-human (FIH) phase I/IIa trial of the prostaglandin E2 (PGE2) receptor 4 (EP4) antagonist HTL0039732 (HTL) as monotherapy and in combination with immunotherapy in patients with advanced solid tumours
Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
Immunotherapy and Vaccine Development
Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas